Internal Medicine · Brooklyn, NY
NPI
1083786362
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
316 86th St
Brooklyn, NY, 11209
Phone (917) 757-3072
Groups this clinician bills Medicare through
Medicare paid, 2024
$100K
1,775 services
Medicare patients, 2024
97
Average age 70
Drug cost, 2024
$2.3M
15,300 prescriptions
Company payments, 2025
$499
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Laila Farhat was code 99213 (office e&m - established), 282 times for 80 patients. In total Laila Farhat billed 1,775 services in 46 codes, and Medicare paid $100K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 282 | 80 | $72.52 | $20K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 245 | 46 | $54.99 | $13K |
| 99457 E&M - Miscellaneous | Office | 238 | 30 | $41.52 | $9,882 |
| 99454 E&M - Miscellaneous | Office | 229 | 28 | $40.88 | $9,362 |
| 36415 Venipuncture Blood Collection | Office | 119 | 73 | $8.65 | $1,029 |
| 99458 E&M - Miscellaneous | Office | 75 | 24 | $32.95 | $2,471 |
| 99214 Office E&M - Established | Office | 74 | 41 | $103.47 | $7,657 |
| G0008 Administration of influenza virus vaccine | Office | 42 | 40 | $36.91 | $1,550 |
| G0009 Administration of pneumococcal vaccine | Office | 34 | 33 | $37.09 | $1,261 |
| 90677 Vaccine Product | Office | 31 | 31 | $290.56 | $9,007 |
| 99212 Office E&M - Established | Office | 29 | 15 | $49.98 | $1,449 |
| G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 29 | 29 | $186.42 | $5,406 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 26 | 14 | $43.45 | $1,130 |
| 93000 Electrocardiogram | Office | 26 | 23 | $10.66 | $277 |
| 91320 Vaccine Product | Office | 23 | 20 | $145.12 | $3,338 |
By year: 2022 $92K for 1,709 services; 2023 $88K for 1,685 services; 2024 $100K for 1,775 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 119 | 73 | $8.65 | $1,029 |
Medicare prescription drug claims, 2024
In 2024, the drug Laila Farhat prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,006 prescriptions and refills. In total Laila Farhat wrote 15,300 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,006 | 1,905 | 214 | $7,180 |
| Metformin Hcl Generic | 981 | 1,663 | 180 | $3,890 |
| Enalapril Maleate Generic | 583 | 1,048 | 117 | $6,290 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 487 | 680 | 84 | $644 |
| Amlodipine Besylate Generic | 438 | 852 | 98 | $1,779 |
| Omeprazole Generic | 423 | 770 | 95 | $2,727 |
| Levothyroxine Sodium Generic | 380 | 657 | 64 | $4,116 |
| Allopurinol Generic | 313 | 562 | 54 | $1,904 |
| Metoprolol Succinate Generic | 307 | 545 | 64 | $3,542 |
| Jardiance Empagliflozin | 304 | 517 | 51 | $300K |
| Sertraline Hcl Generic | 268 | 525 | 61 | $1,170 |
| Gabapentin Generic | 263 | 448 | 64 | $2,062 |
| Ozempic Semaglutide | 228 | 248 | 32 | $226K |
| Rosuvastatin Calcium Generic | 225 | 386 | 42 | $2,002 |
| Famotidine Generic | 224 | 312 | 38 | $11K |
Brand drugs: 2,975 claims; generic drugs: 11,811 claims; opioid claims: 134.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Laila Farhat $499 ($499 in general payments such as food, travel and fees) from 9 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $125.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.